The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...
The Food and Drug Administration (FDA) has greenlit the first-ever self-administered flu vaccine, FluMist. The agency made the announcement on Friday, explaining that FluMist is a convenient nasal ...
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
The FDA approved FluMist for self- or caregiver-administration, making it the first influenza vaccine that does not need to ...
The agency on Friday gave the green light for people who have been screened to give themselves the FluMist nasal spray, which ...